Dare Bioscience (DARE) Tops Q1 EPS by 3c
Dare Bioscience (NASDAQ: DARE) reported Q1 EPS of ($0.27), $0.03 better than the analyst estimate of ($0.30).“The first quarter was ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
